Riding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com
SpliceBio already had the backing from the venture arms of two pharma companies – UCB and Novartis – and two other big players in the industry have participated in an impressive second funding round f
Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to abruptly retire all 17 members of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practic
Vaccine developers are wondering about the fate of products awaiting recommendations after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to abruptly retire all 17 members of the